Articles by Hallie Forcinio - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Hallie Forcinio

Expanding the Use of Child-Resistant Packaging

May 1, 2002

As the use of child-resistant packaging increases, efforts are underway to harmonize global standards and regulations.

PDA Task Force Issues Guidelines to Aid Isolator Users

Mar 1, 2002

When FDA reviewed PDA's Technical Report No. 34 about isolator systems, significant differences of opinion between the organizations came to light.

What Does Pharmacy Automation Mean for Packaging?

Jan 1, 2002

A limited number of container sizes, dispensing lanes, computerized tracking, and polyethylene mailing bags are just a few of the new elements of packaging launched at one company's automated pharmacy facility.

Near-Infrared Inspection Complements Other QC Systems

Oct 2, 2001

NIR quality control technology, relatively new to the pharmaceutical industry, could revolutionize processing and packaging.

Industry Changes OTC Labels as Deadline Approaches

Sep 2, 2001

Manufacturers are gearing up to make labeling chnges required on most over­the­counter pharmaceutical products.

Interphex Presents a Wide Array of Packaging Innovations

Aug 2, 2001

The latest developments in packaging technology made a strong showing at the 2001 Interphex exhibition.

10 Turning Points in Pharmaceutical Packaging

Jul 1, 2001

In the past three decades, several industry-altering episodes have changed the face of pharmaceutical packaging.

Blister News: COC Resin, Foil, and Liidding Innovations

Jun 2, 2001

Cyclic olefin copolymer (COC) resins are showing a number of benefits that could propel their usage in syringe bodies, blister packs, and other packaging components.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here